Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Purchase of 16,378 CAMP shares, $27.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Camp4 Therapeutics Corp (CAMP) | Purchase | 16,378 | $27.0K |
| Jun 12, 2026 | Camp4 Therapeutics Corp (CAMP) | Grant/Award | 28,000 | n/a |
| Sep 11, 2025 | Camp4 Therapeutics Corp (CAMP) | Purchase | 15,151 | $25.0K |
| Jun 27, 2025 | Camp4 Therapeutics Corp (CAMP) | Grant/Award | 9,000 | n/a |
| Oct 15, 2024 | Camp4 Therapeutics Corp (CAMP) | Conversion | 8,917 | n/a |
| Sep 18, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 2,667 | n/a |
| Jul 2, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Sale | 34,837 | $178.4K |
| Jun 21, 2024 | Omega Therapeutics, Inc. (OMGA) | Grant/Award | 25,000 | n/a |
| Jun 7, 2024 | Syros Pharmaceuticals, Inc. (SYRS) | Grant/Award | 4,000 | n/a |
| Sep 19, 2023 | Syros Pharmaceuticals, Inc. (SYRS) | Exercise/Conversion | 2,666 | n/a |